Corpus Intelligence IC Memo — LAKE CHELAN COMMUNITY HOSPITAL 2026-04-26 09:31 UTC
IC Memo — LAKE CHELAN COMMUNITY HOSPITAL
Investment Committee Memorandum | WA | 22 beds | Grade C | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LAKE CHELAN COMMUNITY HOSPITAL

CCN 501334 | CHELAN, WA | 22 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LAKE CHELAN COMMUNITY HOSPITAL is a 22-bed rural/critical access in CHELAN, WA with $24.4M in net patient revenue and a -24.9% operating margin. The hospital serves a payer mix of 51.3% Medicare, 8.6% Medicaid, and 40.1% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.9% to -17.5% (+736bps).

Net Revenue HCRIS$24.4M
Current EBITDA COMPUTED$-6.1M
Operating Margin COMPUTED-24.9%
Occupancy HCRIS24.0%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS59.6%
Distress Probability ML59.4%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
39
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -24.9% places it below the state median. Among 39 size-comparable peers (11-44 beds), the median margin is -9.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (11-44), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LAKE CHELAN COMMUNITY HOSPITAL (Target)WA22$24.4M-24.9%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
JEFFERSON GENERAL HOSPITALWA25$148.0M-3.0%
MASON GENERAL HOSPITALWA25$127.1M-5.3%
KITTITAS VALLEY COMMUNITY HOSPWA25$121.0M2.3%
TRI-STATE MEMORIAL HOSPITALWA25$107.0M0.8%
ISLAND HOSPITALWA43$106.1M-15.0%
ASTRIA SUNNYSIDE HOSPITALWA25$102.5M1.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$513K+210bp18mo
Cost to Collect4.5%2.5%$489K+200bp12mo
Denial Rate Reduction12.0%6.5%$484K+198bp12mo
A/R Days Reduction5200.0%3800.0%$297K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$513K
Cost to Collect
$489K
Denial Rate Reduction
$484K
A/R Days Reduction
$297K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$-6.1M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$-4.3M
Current Margin-24.9%
Pro Forma Margin-17.5%
WC Released (1x)$937K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-9.3M$-22.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-9.3M$-27.3M0.00x-100.0%
Bull Case9.0x11.0x$-8.4M$-24.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-8.4M$-29.2M0.00x-100.0%
Bear Case11.0x10.0x$-10.3M$-28.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-10.3M$-34.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 24.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 11-44 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-14.7% / P50=-9.4% / P75=-4.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.